Iazsmin Ventura to C-Reactive Protein
This is a "connection" page, showing publications Iazsmin Ventura has written about C-Reactive Protein.
Connection Strength
0.344
-
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 03; 109(3):688-696.
Score: 0.344
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.